Advertisement

Topics

Latest "PinPoint Commercial, LP" News Stories

07:04 EDT 20th September 2018 | BioPortfolio

Here are the most relevant search results for "PinPoint Commercial, LP" found in our extensive news archives from over 250 global news sources.

More Information about PinPoint Commercial, LP on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PinPoint Commercial, LP for you to read. Along with our medical data and news we also list PinPoint Commercial, LP Clinical Trials, which are updated daily. BioPortfolio also has a large database of PinPoint Commercial, LP Companies for you to search.

Showing "PinPoint Commercial" News Articles 1–25 of 2,100+

Thursday 20th September 2018

Photocure ASA: Daniel Schneider appointed Chief Executive Officer

Oslo, Norway, 20 September 2018: Photocure ASA (OSE: PHO), announces today that Daniel Schneider has been appointed President and Chief Executive Officer of Photocure. Mr Schneider joins Photocure from the position of General Manager for Ablynx N.V. in North America. "I am pleased to announce Dan Schneider as our new President and Chief Executive Officer. Photocure is entering a perio...


VIFOR PHARMA ANNOUNCES CHANGES IN MANAGEMENT

Vifor Pharma Ltd. / VIFOR PHARMA ANNOUNCES CHANGES IN MANAGEMENT . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Barbara Angehrn joins Vifor Pharma as Chief Business Officer Patrick Treanor takes over from Scott Garland as President of Relypsa Vifor Pharma announced today changes to its manage...

Wednesday 19th September 2018

Stream Bio launches novel bioimaging probes with 2BScientific

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimagin...


Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for Third Quarter 2018 Earnings Release and Conference Call

Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized and the Company has declared a quarterly cash dividend of $0.23 per common share and unit for the quarter ending September 30, 2018. “We are proud to declare and pay our 21st consecutive quarterly dividend. Our high-qualit...

Scilex Announces Pricing and Availability of ZTlido for the Commercial Launch of its First Product in October of 2018

Scilex Pharmaceuticals a subsidiary of Sorrento Therapeutics (NASDAQ: SRNE) announced that the Wholesale Acquisition Cost (WAC) for ZTlido (lidocaine topical system) 1.8% (ZTLIDO) is $8.98 per patch and is now listed in pricing compendia. Scilex expects commercial availability of ZTlido through wholesale distribution in October 2018. As quoted in the press release: “We are excited … Contin...

Nuvo Pharmaceuticals to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

NewsUpon closing of the Proposed Transaction, Nuvo would pay Aralez $110 million in cash,

Nexstim Plc to Present Depression Led Strategy at Investor Conference Sijoittaja 2018 in Helsinki

Press release, Helsinki, 19th September 2018 at 4:00 PM EEST Nexstim Plc to Present Depression Led Strategy at Investor Conference Sijoittaja 2018 in Helsinki Nexstim Plc to host a Conference Call / Webcast on Tuesday 25th September at 4pm EEST to Provide Strategic Update Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or the "Company"), the targeted neurom...

Aetna Announces CEO to Lead New Aetna Medicaid Plan in Kansas

Aetna (NYSE: AET) has named Keith Wisdom as the Chief Executive Officer for Aetna Better Health® of Kansas, Aetna’s Medicaid health plan in the state. Aetna Better Health was recently selected by the Kansas Department of Health and

Changes in responsibility areas of the Orion Group Executive Management Board

ORION CORPORATION       STOCK EXCHANGE RELEASE      19 SEPTEMBER 2018 at 11.45 a.m. EEST                      Changes in responsibility areas of the Orion Group Executive Management Board The following changes have been decided in responsibility areas of the Orion Group Executive Management Board: As of 1 October, 2018: Mr. Markku Huhta-Koivisto,...

LIDDS receives NanoZolid® technology patent protection until 2037

The European Patent Office has approved a novel patent for LIDDS NanoZolid® technology. LIDDS patent protection for the drug delivery technology is now extended for at least another nineteen years. The new patent protects fundamental aspects of the production process of NanoZolid® drug delivery formulations. The patent covers all NanoZolid formulations that are in development by LIDDS. ...

Novel deep learning drug discovery platform gets £1 million innovation boost

September 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens...

SkinBioTherapeutics plc: Human study commenced

Manchester, UK – 19 September 2018 - SkinBioTherapeutics plc (AIM: SBTX,  the “Company”), a life science company focused on skin health, confirms that it has commenced its human study being carried out on its SkinBiotix® technology. There are three elements to the human study: the first, already underway, is to assess skin irritancy; the second, due to commence on 20...

Biodex Supports Screening Events for Falls Prevention Awareness Day

Balance technology users receive educational resources, marketing materials and a photo contest as they help keep seniors on their feet. SHIRLEY, N.Y. (PRWEB) September 19, 2018 To honor this year’s Falls Prevention Awareness Day, Biodex Medical Systems, Inc. is encouraging medical facilities and wellness centers to get involved in preventing falls in their communities. Throughout the month, th...

Tuesday 18th September 2018

Scilex Announces Pricing and Availability of ZTlido™ for the Commercial Launch of its First Product in October of 2018

SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (Sorrento), today announced that the Wholesale Acquisition Cost (WAC) for ZTlido™ (lidocaine topical system) 1.8% (ZTLIDO) is $8.98 per patch and is now listed in pricing compendia. Scilex expects commercial availability of ZTlido through wholesale dis...

Would Your Reps Pass The Empathy Test?

Make no mistake about it, the role of the pharmaceutical sales representative is in flux. But, then, when has it not been? In truth, looking at today’s small, data-fueled sales forces, it’s hard to conceive that back in the early nineties more than 100,000 pharma reps were plying their trade in the US alone. Back then, the name of the game was – in reductive terms – to flog as many blockbu...

Discomfort or death? New study maps hot spots of child mortality from diarrhea in Africa

(Institute for Health Metrics and Evaluation) New high-resolution maps pinpoint areas across Africa with concentrations of child deaths from diarrhea and show uneven progress over 15 years to mitigate the problem.The study, covering 2000 to 2015, maps the entire African continent in 5x5 square kilometer units and was published today in The New England Journal of Medicine. National and provincial m...

Children’s Hospital Los Angeles Team Identifies Developmental Stage for No. 1 Eye Tumor in Children

Finding in retinoblastoma could lead to new interventions Investigators at Children's Hospital Los Angeles have been able to pinpoint the exact stage of development of the human retina, when cells can grow out of control and form cancer-like masses. The finding could open the door for future interventions in retinoblastoma (RB), a tumor of the retina t...

OUE To Acquire 60% Stake In Bowsprit

- Acquisition of Bowsprit is part of OUE's plan to grow its asset management business to over S$10 billion by 2019  SINGAPORE, Sept. 18, 2018 /PRNewswire/ -- SGX-ST Main Board-listed integrated property developer OUE Limited ("OUE") and its listed subsidiary, OUE Lippo Healthcare Limited ("OUELH") today announced the proposed

Nemaura Signs Letter of Intent for SugarBEAT Commercial Launch in Qatar

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, today announced that it has signed a non-binding letter of intent for an exclusive licensing agreement with Al-Danah Medical Co for the commercial launch of sugarBEAT® in Qatar. As …...

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

Medtronic Receives FDA Approval for Revised TAVR Labeling and Begins Investigational Study of Low Risk Patients with Bicuspid Valves DUBLIN - September 18, 2018 - Medtronic plc (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a single-arm study to evaluate the CoreValve Evolut(TM)TAVR syst...

PPG Completes COLORFUL COMMUNITIES Project at Wadih Jorge Maluf School in Sumaré, Brazil

PPG (NYSE: PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Sumaré, São Paulo, Brazil, that helped revitalize the Wadih Jorge Maluf School in the Matão district. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company ...

Alarm Raised on Safety of Commercial Probiotics

(MedPage Today) -- Few data on potential harms, for which there are grounds for concern

Verana Health Appoints Three Key Executives as Company Builds Team to Expand Leading Specialty Data Platform

Marc Berger Joins as Senior Vice President and General Counsel Ellenmarie Rhone Joins as Senior Vice President of People and Culture Don Butler Joins as Vice President of Life Science, Commercial Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets, today ...

Xellia Pharmaceuticals Opens North American Commercial Office in Chicago Ahead of Launching Value-Added Anti-Infective Injectable Drug Products

New anti-infective products to launch in US hospital markets Xellia Pharmaceuticals (Xellia or the Company), a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections, today announced that it has opened a new office in Buffalo Grove, near Chicago, Illinois to accomm...

Montecito Acquires Medical Office Building of Leading Primary Care Provider in Rhode Island

Montecito Medical Real Estate, a premier owner of medical office buildings throughout the U.S., has acquired the University Medicine Medical Office Building in East Providence, Rhode Island. University Medicine, which is part of


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks